The risk for sudden cardiac death (SCD) in adolescents and young adults with hypertrophic cardiomyopathy (HCM) is "an order of magnitude lower" than most recent estimates would indicate, a report ...

Hypertrophic cardiomyopathy (HCM) is a genetic disease characterized by abnormal myocardial hypertrophy, which can lead to a wide clinical spectrum, including sudden cardiac death and heart failure.

Hypertrophic cardiomyopathy (HCM) is a genetic heart condition affecting about 1 in 500 people and is one of the leading causes of sudden cardiac death (SCD) in people under 35, including among ...

HCM is a genetic disease, usually caused by mutations in sarcomere proteins such as myosin, actin, tropomyosin, and myosin-binding protein C.

The American College of Cardiology (ACC) and the American Heart Association (AHA) today released a new clinical guideline for effectively managing individuals diagnosed with hypertrophic ...

Learn about surgical options for hypertrophic cardiomyopathy (HCM), including septal myectomy, septal ablation, and heart ...

The AI model MAARS showed good results flagging arrhythmic risk in hypertrophic cardiomyopathy. MAARS takes inputs from electronic medical records, cardiac MRI scans with late gadolinium enhancement, ...

Updates to national guidelines for the management of hypertrophic cardiomyopathy (HCM) endorse cardiac myosin inhibitor use in certain cases, greenlight more intensive physical activity, and expand ...

Learn how hypertrophic cardiomyopathy (HCM) affects families, the importance of genetic testing, and why regular screening is vital for at-risk relatives.